DCP-LA

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDCP-LA
Drug Alias NameDCP-LA-(alpha,beta)linoleic acid derivative (Hyogo College of Medicine)alpha,beta-DCP-LADCP-LA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-9 inhibitorsProtein kinase C epsilon type stimulantsCaspase-3 inhibitors
TargetsProtein kinase C epsilon typeCaspase-9Caspase-3
Therapy Area/IndicationsCognition DisordersNerve DegenerationStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHyogo College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHyogo College Of Medicine
Active IndicationsN/A
Inactive IndicationsCognition DisordersNerve DegenerationStroke

Other Information

ATC CodeN/A
Related LinksN/A